*Some Market data delayed by 15 mins.

Exact Sciences Corp

Symbol: EXAS (NASDAQ)
0.00 ▼ (-100.00%) -56.190

Company Description:
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Key Stats
  • Today's Open: $0
  • Today's High: $0
  • Today's Low: $0
  • Today's Volume: 0
  • Yesterday Close: $56.19
  • Yesterday High: $56.925
  • Yesterday Low: $55.56
  • Yesterday Volume: 1.75M
  • Last Min Volume: 0
  • Last Min High: $0
  • Last Min Low: $0
  • Last Min VWAP: $0
Company Profile
  • Name: Exact Sciences Corp
  • Website: https://www.exactsciences.com
  • Listed Date: 2001-01-30
  • Location: MADISON, WI
  • Market Status: Active
  • CIK Number: 0001124140
  • SIC Code: 8071
  • SIC description: SERVICES-MEDICAL LABORATORIES
  • Market Cap: $10.64B
  • Round Lot: 100
  • Outstanding Shares: 189.32M
  • Asset Type: CS
RECENT FILINGS FOR EXAS
Filing Date Filing Type Format
2025-09-08 SCHEDULE 13G/A View
2025-08-14 4 View
2025-08-13 144 View
2025-08-07 4 View
2025-08-07 4 View
2025-08-06 10-Q View
2025-08-06 8-K View
2025-07-17 SCHEDULE 13G/A View
2025-07-16 144 View
2025-07-11 S-8 POS View
2025-07-11 S-8 View
2025-06-24 11-K View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
2025-06-16 4 View
Latest News on EXAS

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.